Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters.com
Teva continues to wobble as rival drug receives FDA approval - The Jerusalem Post
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply | FiercePharma
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
FDA places hold on Teva, Regeneron back pain trial - PharmaTimes
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. | FDA
Generic EpiPen Cleared By FDA As Teva challenges Mylan
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva Issues Recall of Tainted Blood Pressure Medicine, the Latest Global Recall for Valsartan | BioSpace
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | FiercePharma
FDA Roundup AstraZeneca Teva Amgen And More
Mylan's fight against Teva highlights logjam created by FDA petitions | Modern Healthcare
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017 | RAPS
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Teva gets FDA green light for first generic Sabril | Drug Store News
FDA accepts Teva-MedinCell's new drug application for schizophrenia drug
